Treatment advances in systemic juvenile idiopathic arthritis

Academic Article


  • Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory condition that is distinct from other forms of childhood arthritis. Recently, biologic agents that specifically inhibit the cytokines interleukin (IL)-1 and IL-6 have demonstrated remarkable clinical effectiveness and confirmed the importance of these cytokines in the disease process. Future studies are likely to optimize the care of children with systemic arthritis and further elucidate the disease pathogenesis. © 2014 Faculty of 1000 Ltd.
  • Published In

  • F1000prime reports  Journal
  • Digital Object Identifier (doi)

    Author List

  • Beukelman T
  • Volume

  • 6